Global Psoriasis Treatment Market
Overview:
Psoriasis is a skin disease that causes red, itchy scaly patches, most commonly on the knees, elbows, trunk, and scalp. It is a common, chronic disease with no cure. Treatment includes light therapy, topical ointments, and medication; can offer relief. There are five types of psoriasis, such as Pustular, Inverse, Guttate, Plaque, and Erythrodermic. Of which, the most prevalent type is Plaque psoriasis, accounting for around 90% of reported cases. Guttate psoriasis shows up on the skin as red, scaly, small, teardrop-shaped spots. Pustular psoriasis shows up on the skin with white bumps filled with pus near or inside red skin blotches. Inverse psoriasis causes red and inflamed lesions in the skin folds of the body. Whereas, Erythrodermic psoriasis is one of the most severe types of psoriasis; can develop from other types.
Drivers:
Increasing cases of psoriasis and increasing demand for psoriasis treatment is expected to aid in the growth of the global psoriasis treatment market over the forecast period.
As per the International Federation of Psoriasis Associations, more than 3% of the worldโs population has some form of psoriasis. Treatment helps control signs & symptoms of psoriasis. Treatment methods include exposure to ultraviolet B (UVB) light, administering steroid, and immunosuppressive like methotrexate. More than 70% cases of psoriasis can be managed with topical creams. Ointments and creams, such as calcipotriol and corticosteroid can treat mild-to-moderate psoriasis effectively. For severe cases, creams are used in combination with oral medications such as cyclosporin, acitretin, and methotrexate.
๐๐๐ญ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/99
Topical drugs, such as retinoid, hydroxyanthrone, vitamin D, and corticosteroids, are also used in treatment of psoriasis. Topical corticosteroids are often prescribed to treat mild-to-moderate cases of psoriasis. Moreover, they are used to treat widespread patches of damaged skin, and are suitable for sensitive areas such as skin folds and face. While, scalp solutions and medicated foams are used to treat patches on the scalp. Calcipotriene (Dovonex) is used to treat mild-to-moderate psoriasis; can be used alone or in combination with other topical medications.
Regional Insights:
North America is expected to witness lucrative growth in the global psoriasis treatment market, owing to the high prevalence of psoriasis, increasing demand for psoriasis treatment, favorable reimbursement policies, commercialization of new diagnostic technology, and better medical facilities. For instance, according to a study published in September 2013 in Cleveland Clinic, each year, over 150,000 new cases of psoriasis registered in the United States.
Moreover, Asia Pacific is expected to witness robust growth in the global psoriasis treatment market due to the large patient pool and increasing demand for psoriasis treatment in the region. According to the study published in 2015 in Medical Journal of Malaysia, the prevalence of psoriasis was 0.05% to 0.1% in Japan compared to Taiwan 0.2% and China 0.5%. While, the prevalence of psoriasis was 0.4% to 2.8% in India.
๐๐จ ๐ ๐๐ญ ๐๐จ๐ซ๐ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ @ https://www.coherentmarketinsights.com/insight/request-sample/99
Competitive Landscape:
Major players active in the global psoriasis treatment market are Glenmark Pharmaceuticals, Cipla Ltd., Rowan Bioceuticals Private Limited, Johnson & Johnson, Stiefel Laboratories Inc. (GlaxoSmithKline plc), Novartis, Win Medicare Pvt. Ltd., and Sun Pharmaceuticals Industries Ltd., among others.
Key Developments:
In October 2017, Glenmark Pharmaceuticals Ltd. announced the launch of an oral drug, named Apremilast, for the treatment of psoriasis in India.
In October 2018, Sun Pharmaceuticals announced the launch of a novel drug, named Ilumya, to treat plaque psoriasis in the U.S.
In July 2019, Cipla and Alvotech entered into partnership to commercialize an adalimumab biosimilar, AVT02, used to treat plaque psoriasis and rheumatoid arthritis.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐ @ https://www.coherentmarketinsights.com/promo/buynow/99
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Psoriasis Treatment Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Psoriasis Treatment Industry Impact
Chapter 2 Global Psoriasis Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Psoriasis Treatment (Volume and Value) by Type
2.3 Global Psoriasis Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Psoriasis Treatment Sales, Consumption, Export, Import by Regions
Chapter 5 North America Psoriasis Treatment Market Analysis
Chapter 6 East Asia Psoriasis Treatment Market Analysis
Chapter 7 Europe Psoriasis Treatment Market Analysis
Chapter 8 South Asia Psoriasis Treatment Market Analysis
Chapter 9 Southeast Asia Psoriasis Treatment Market Analysis
Chapter 10 Middle East Psoriasis Treatment Market Analysis
Chapter 11 Africa Psoriasis Treatment Market Analysis
Chapter 12 Oceania Psoriasis Treatment Market Analysis
Chapter 13 South America Psoriasis Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Psoriasis Treatment Business
Chapter 15 Global Psoriasis Treatment Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodologyโฆ.
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837